Hey biotech researcher, it's a thing a buddy of mine wrote in MetaStock. Here's one for you, and the rest...
MNKD.
I've been looking more into this one and it looks very promising. Dec 29th they have a possible FDA announcement on approval of an insulin drug, Afrezza, and if it gets approved, I think could be a new DNDN possibly. I took a position in the Jan'12 $5 calls today at $3.40. Could be a $20+ stock.